Nurse Capital Strengthens Leadership with Dan Weberg's Expertise
Nurse Capital is excited to announce the addition of Dan Weberg, Ph.D., MHI, RN, FAAN as General Partner, marking a significant step forward in its mission to support nurse-led startups. With over ten years of experience advising startups and venture firms, Dr. Weberg is recognized as a thought leader in healthcare innovation and organizational change. He currently serves as the Executive Director of Nursing Workforce Development and Innovation at Kaiser Permanente, where he has also been instrumental in leadership roles focused on innovation and technology strategies across multiple regions.
Dr. Weberg's rich professional history includes leading innovation initiatives at respected organizations such as Trusted Health and Ascension, as well as at The Ohio State University. His diverse experience with startups, ranging from fledgling ventures to companies spun off from tech giants like Google, positions him uniquely to contribute to Nurse Capital’s investment strategy. "Nurses are at the forefront of healthcare innovation, touching every aspect from device development to patient care management," said Dr. Weberg. He believes this perspective is critical in guiding investments toward transformative healthcare solutions.
Beth A. Brooks, Ph.D., RN, FACHE, co-founder and CEO of Nurse Capital, emphasized the strategic fit Dr. Weberg brings to the team, stating, "His specialized knowledge in healthcare innovation will greatly enhance our investment strategies and bolster our existing clinical and operational capabilities."
Dr. Weberg steps into the role previously held by Nurse Capital co-founder Marla Weston, Ph.D., RN, FAAN, who will remain involved with the organization as a Limited Partner and board advisor. Dr. Weston’s ongoing presence will ensure continuity and support as Nurse Capital expands its influence in the healthcare sector.
Nurse Capital, based in Chicago, is dedicated to investing in early-stage businesses led by nurses that demonstrate high growth potential and aim to revolutionize healthcare practices. The firm targets investments in nurse entrepreneurs who apply innovative solutions to optimize patient care and streamline healthcare processes.
Through his role at Nurse Capital, Dr. Weberg aims to guide capital towards underfunded and overlooked entrepreneurs in the healthcare field, emphasizing the pivotal role that nurses play in healthcare activities. "Joining Nurse Capital fills me with enthusiasm. I look forward to leveraging my background to advance the projects and startups that make a genuine impact in healthcare," he stated.
This new appointment is a testament to Nurse Capital's commitment to fostering innovative solutions in healthcare while highlighting the critical role nurses play within this industry. By integrating Dr. Weberg's insights, Nurse Capital is set to strengthen its mission and expand its portfolio of nurse-led innovations, ultimately contributing towards a healthier future for all stakeholders in the healthcare system.
For more information on Nurse Capital and its initiatives, please visit
Nurse Capital.
Conclusion
In summary, the appointment of Dr. Dan Weberg exemplifies Nurse Capital's dedication to enhancing the landscape of healthcare innovation. As nurse-led ventures increasingly shape the future of the industry, Dr. Weberg's leadership is poised to influence significant advancements that will benefit patients and healthcare providers alike.